Tackling the New Bottleneck of Drug Discovery
Manage episode 439482484 series 3551733
Markus Gershater, chief scientific officer and co-founder of Synthace sits down with Amar Drawid to discuss Synthace’s AI-based platform that enables drug developers to design complex experiments, run them, and capture and analyze the data all in an automated way.
16 episode